DBVT vs. PVLA

Last updated Jun 4, 2026

DBVT (DBV Technologies S.A.) and PVLA (Palvella Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, DBVT returned 122.92% vs 372.26% for PVLA. At a 0.12 correlation, their price movements are largely independent.

Performance

DBVT vs. PVLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DBV Technologies S.A. (DBVT) and Palvella Therapeutics, Inc (PVLA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DBVT achieves a -7.67% return, which is significantly lower than PVLA's 10.27% return.

DBVT

• 1D: -2.91%
• 1M: -9.09%
• YTD: -7.67%
• 6M: 36.26%
• 1Y: 122.92%
• 3Y*: -3.83%
• 5Y*: -20.40%
• 10Y*: -25.38%

PVLA

• 1D: 10.27%
• 1M: -9.55%
• YTD: 10.27%
• 6M: 25.58%
• 1Y: 372.26%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DBVT vs. PVLA - Yearly Performance Comparison

	2026 (YTD)	2025	2024
DBVT DBV Technologies S.A.	-7.67%	520.39%	-4.04%
PVLA Palvella Therapeutics, Inc	10.27%	772.25%	-6.47%

Correlation

The correlation between DBVT and PVLA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (All Time) Calculated using the full available price history since Dec 17, 2024	0.12

Fundamentals

Market Cap DBVT : $1.52B PVLA : $1.30B
EPS DBVT : -$1.89 PVLA : -$3.75
PB Ratio DBVT : 7.29 PVLA : 46.41
Total Revenue (TTM) DBVT : $0.00 PVLA : $0.00
Gross Profit (TTM) DBVT : -$8.90M PVLA : $0.00
EBITDA (TTM) DBVT : -$159.48M PVLA : -$14.75M

Return for Risk

DBVT vs. PVLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DBVT

DBVT Risk / Return Rank: 83
DBVT Sharpe Ratio Rank: 82
DBVT Sortino Ratio Rank: 83
DBVT Omega Ratio Rank: 78
DBVT Calmar Ratio Rank: 89
DBVT Martin Ratio Rank: 83

PVLA

PVLA Risk / Return Rank: 96
PVLA Sharpe Ratio Rank: 98
PVLA Sortino Ratio Rank: 95
PVLA Omega Ratio Rank: 92
PVLA Calmar Ratio Rank: 98
PVLA Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DBVT vs. PVLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DBV Technologies S.A. (DBVT) and Palvella Therapeutics, Inc (PVLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DBVT	PVLA	Difference
Sharpe ratio: Return per unit of total volatility	1.56	4.57	-3.01
Sortino ratio: Return per unit of downside risk	2.58	4.12	-1.54
Omega ratio: Gain probability vs. loss probability	1.29	1.49	-0.20
Calmar ratio: Return relative to maximum drawdown	4.44	12.54	-8.10
Martin ratio: Return relative to average drawdown	7.82	28.59	-20.77
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DBVT vs. PVLA - Sharpe Ratio Comparison

The current DBVT Sharpe Ratio is 1.56, which is lower than the PVLA Sharpe Ratio of 4.57. The chart below compares the historical Sharpe Ratios of DBVT and PVLA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DBVT	PVLA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.56	4.57	-3.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.30	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	4.30	-4.54

Drawdowns

DBVT vs. PVLA - Drawdown Comparison

The maximum DBVT drawdown since its inception was -99.52%, which is greater than PVLA's maximum drawdown of -31.48%. Use the drawdown chart below to compare losses from any high point for DBVT and PVLA.

Drawdown Indicators

	DBVT	PVLA	Difference
Max Drawdown Largest peak-to-trough decline	-99.52%	-31.48%	-68.04%
Max Drawdown (1Y) Largest decline over 1 year	-27.87%	-29.93%	+2.06%
Max Drawdown (3Y) Largest decline over 3 years	-89.29%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-96.34%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.52%	—	—
Current Drawdown Current decline from peak	-96.41%	-22.19%	-74.22%
Average Drawdown Average peak-to-trough decline	-70.27%	-10.66%	-59.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.77%	13.10%	+2.67%

Volatility

DBVT vs. PVLA - Volatility Comparison

The current volatility for DBV Technologies S.A. (DBVT) is 9.52%, while Palvella Therapeutics, Inc (PVLA) has a volatility of 24.98%. This indicates that DBVT experiences smaller price fluctuations and is considered to be less risky than PVLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DBVT	PVLA	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.52%	24.98%	-15.46%
Volatility (6M) Calculated over the trailing 6-month period	57.53%	62.87%	-5.34%
Volatility (1Y) Calculated over the trailing 1-year period	79.32%	82.14%	-2.82%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	92.75%	82.90%	+9.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.49%	82.90%	+2.59%

Dividends

DBVT vs. PVLA - Dividend Comparison

Neither DBVT nor PVLA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both DBVT and PVLA in my portfolio?

DBVT and PVLA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DBVT or PVLA?

PVLA has higher volatility (24.98%) compared to DBVT (9.52%). In terms of maximum drawdown, DBVT dropped -99.52% vs PVLA's -31.48%.

Which has better risk-adjusted returns?

PVLA currently has the higher Sharpe Ratio (4.57 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.